Published Date: 10 Mar 2023
Most studies used to examine small amounts of DNA in early human embryos do not involve gene therapy. As a result...
Read Full NewsSwiss generic drugmaker Sandoz filed a draft anti-dumping complaint with the European Commission over Chinese imports of the antibiotic ingredient amoxicillin.
Dr Bishal Gyawali explores why lowering the bar for drug approvals is a fallacy and why asking for better evidence is a sign of patient advocacy, not an attack on innovation.
Quantitative T2* MRI is feasible and reproducible for detecting microvasculopathy-related iron deposition in the soft tissues of the fingers.
An observational study suggests that bone mineral density may serve as a marker of systemic health.
Patients with autoimmune diseases who experience ocular inflammation while on adalimumab have an increased risk of developing antibodies against the drug, according to a recent retrospective study.
The World Health Organization has recommended prioritizing three experimental treatments for the Bundibugyo strain of Ebola.
Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.
1.
United States Lung Cancer Screening Rates Remain Low. s. in particular in the South.
2.
Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone
3.
Higher Binge Drinking Rates Linked to New Cannabis Laws.
4.
Nasal therapeutic HPV vaccine could prevent cervical cancer
5.
Exercise could ease symptoms for people with chronic lymphocytic leukemia, support and guidance are lacking: Study
1.
Harnessing Cuproptosis: A Novel Nanomedicine Strategy for Triple-Negative Breast Cancer
2.
The Latest Advances in Glioblastoma Treatment and Prevention
3.
The Millionaire's Battle: Does Mark Cuban Have Cancer?
4.
Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII
5.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation